Status:
COMPLETED
A Simple Clinical Tool to Help Diagnose Pulmonary Embolism: Phase 1
Lead Sponsor:
Mayo Clinic
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this project is to determine if the change in oxygen saturation during deep inspiration ("augmented pulse oximetry") can be used as a method to rule out pulmonary embolism (PE). The invest...
Detailed Description
Patients will be identified and enrolled by the Mayo Clinic St. Marys Emergency Department staff as they are undergoing medical care in the Emergency Department. The investigators will calculate the ...
Eligibility Criteria
Inclusion
- 18 years of age or greater.
- Agrees and able to participate in the study.
- Room air SpO2 (oxygen saturation) less than 92% and newly-diagnosed PE (or controls with no PE) based on CT angiogram result.
Exclusion
- Clinical concern for instability.
- Systolic blood pressure less than 100 mm Hg.
- Heart rate ≥140 beats per minute.
- Oxygen saturation less than 85% with more than 4 L supplemental oxygen.
- Unable to participate/comply with instructions for using the incentive spirometer.
- Patients from the Federal Medical Center in Rochester, Minnesota.
- Patients who do not speak English (due to the need for expediency).
- Patients will be under the care of the Emergency Department team who have the skills and resources to monitor and treat patients if they were to become unstable.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT01898637
Start Date
June 1 2013
End Date
November 11 2024
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905